EROS – PT 141 15mg, Oxytocin 2.5mg Spray (17.5mg Blend)
$129.99
- Contents: PT-141 15mg / Oxytocin 2.5mg
- Total Listed Material: 17.5mg
- Solution Volume: 15mL
- Bottle Capacity: 30mL
- Output Per Bottle: Approximately 100 sprays
- Supplied Output Per Spray: 170.50mcg
- Storage: Refrigerate after opening
- Shelf Life: 6 months
- Format: Research spray formulation
49 in stock
EROS Peptides – PT-141 15mg / Oxytocin 2.5mg Advanced Research Spray
EROS peptides research spray combines PT-141 15mg and Oxytocin 2.5mg for a total listed material quantity of 17.5mg. The formulation contains 15mL of solution in a 30mL bottle and provides approximately 100 sprays according to the supplied specifications.
The product information lists an output of 170.50mcg per spray, refrigeration after opening, and a six-month shelf life.
EROS Peptides PT-141 / Oxytocin Research Spray
The EROS peptides formulation contains two specified components:
| Specification | Product Information |
|---|---|
| PT-141 | 15mg |
| Oxytocin | 2.5mg |
| Total Listed Material | 17.5mg |
| Solution Volume | 15mL |
| Bottle Capacity | 30mL |
| Approximate Output | 100 sprays |
| Supplied Output Per Spray | 170.50mcg |
| Storage | Refrigerate after opening |
| Shelf Life | 6 months |
The component quantities and spray specifications describe the supplied research formulation. They should not be interpreted as human dosing or administration recommendations.
EROS Peptide Blend Composition
The singular search variation eros peptide may be used when researching this formulation.
Its supplied composition is:
PT-141: 15mg
Oxytocin: 2.5mg
Total: 17.5mg
The two component quantities add to the stated 17.5mg total.
Because the product contains two separately named materials, the complete formulation should be distinguished from research involving PT-141 or Oxytocin individually.
No molecular sequences, molecular formulas, molecular weights, PubChem CIDs, or CAS numbers were supplied for the individual components in the information provided for this product, so those specifications are not being inferred here.
EROS Peptides Spray Specifications
The EROS peptides product contains 15mL of solution in a bottle with a total capacity of 30mL.
According to the supplied specifications, one bottle provides approximately:
100 sprays
The stated output is:
170.50mcg per spray
These values provide useful information for product documentation and controlled laboratory research.
The spray count is approximate, so actual physical output may depend on the dispensing system. No additional pump or spray-volume specification was supplied.
Output Per Spray – Specification Note
There is an arithmetic difference within the supplied product information that researchers should document.
The listed components total:
15mg + 2.5mg = 17.5mg
This equals 17,500mcg total listed material.
If exactly 100 equal sprays contained the entire listed 17.5mg, the mathematical average would be 175mcg per spray.
However, the supplied product specification states 170.50mcg per spray and describes the bottle output as approximately 100 sprays.
Because the spray count is approximate and no additional manufacturing or dispensing information was supplied, this page preserves 170.50mcg per spray as the supplied specification rather than silently replacing it with a calculated value.
ErosPeptides Research Terminology
The joined search variation erospeptides may appear when researchers look for information about the EROS formulation.
Regardless of keyword formatting, laboratory documentation should rely on the actual supplied product characteristics:
- PT-141 15mg
- Oxytocin 2.5mg
- 17.5mg total listed material
- 15mL solution volume
- 30mL bottle
- Approximately 100 sprays
- 170.50mcg stated output per spray
- Refrigeration after opening
- Six-month shelf life
These specifications provide a more precise description than keyword variations alone.
PT-141 / Oxytocin Multi-Component Research
The EROS peptides formulation combines PT-141 and Oxytocin within a single research spray.
Researchers should distinguish evidence concerning either isolated component from evidence concerning a combination.
A publication examining PT-141 independently does not automatically establish the same experimental observations for a PT-141/Oxytocin formulation. The same limitation applies when interpreting research involving Oxytocin alone.
Experimental interpretation should remain tied to the actual formulation, research model, concentration, controls, methodology, and endpoints investigated.
EROS Peptides Reviews – Evaluating Research Information
The phrase eros peptides reviews reflects search interest in evaluations and experiences concerning products carrying this name.
This product description does not fabricate or reproduce customer reviews.
For research procurement, more objective factors to examine include:
- Clearly stated composition
- Total material quantity
- Solution volume
- Bottle capacity
- Product format
- Storage information
- Shelf-life information
- Available molecular documentation
- Appropriate research-only labeling
User-generated reviews and anecdotal reports should also be distinguished from controlled scientific evidence.
EROS Peptides Legit – Research Verification
Searches for eros peptides legit indicate an interest in product authenticity or credibility.
A keyword or product description alone cannot establish authenticity.
Researchers should instead evaluate available documentation, labeling, product specifications, molecular information, quality documentation when available, and consistency between supplied product data and the material received.
This page therefore does not make an unsupported claim that a product is “legit” based solely on its catalog listing.
Storage and Six-Month Shelf Life
According to the supplied product information, this research spray should be:
Refrigerated after opening.
The stated shelf life is:
6 months
No specific refrigeration temperature range or additional storage conditions were supplied, so none are being inferred.
Researchers should document storage conditions and the date of opening when these factors are relevant to experimental consistency.
Laboratory Research Considerations
Controlled investigation involving an EROS peptides multi-component formulation should use clearly defined methodology and appropriate experimental controls.
Relevant considerations may include:
- Identity of both components
- Material quantity
- Research concentration
- Solution volume
- Research model
- Appropriate controls
- Experimental conditions
- Analytical methodology
- Experimental endpoints
- Storage conditions
- Reproducibility
- Data interpretation
Researchers should distinguish observations involving the complete formulation from evidence involving either component independently.
Research Documentation
Laboratory records for this product may include:
- EROS product name
- PT-141 quantity
- Oxytocin quantity
- Total listed material
- Solution volume
- Bottle capacity
- Approximate spray count
- Stated output per spray
- Storage requirements
- Shelf life
- Experimental model
- Controls
- Analytical methodology
- Experimental endpoints
Documenting these specifications supports clearer interpretation and comparison across experiments.
Related OROS Research Sprays
Researchers exploring another multi-component spray can review ÆTHER – Adamax / Adalank / PE-22-28 / Pinealon Spray.
The current formulation is cataloged as EROS – PT-141 / Oxytocin Spray.
Researchers can also explore REM Support – Epithalon / Pinealon / DSIP Spray as a separately specified multi-component research formulation.
A single named research spray option is Semax N-Acetyl Amidate Spray 25mg.
Each product has its own composition and should not be considered chemically or experimentally interchangeable.
Scientific Research Resources
Researchers can use PubChem to investigate available molecular records and chemical identifiers for separately identified research compounds.
Peer-reviewed biomedical and experimental literature can be searched through PubMed.
When reviewing scientific publications, researchers should verify the exact compound or combination, research model, concentration, methodology, controls, and endpoints actually investigated.
EROS Peptides Research FAQ
What are EROS peptides in this product?
The supplied EROS formulation is a research spray containing PT-141 15mg and Oxytocin 2.5mg, providing 17.5mg total listed material.
How much solution is supplied?
The bottle contains 15mL of solution.
What is the bottle capacity?
The supplied bottle capacity is 30mL.
How many sprays does one bottle provide?
The supplied specification states approximately 100 sprays per bottle.
What is the output per spray?
The supplied product information states 170.50mcg per spray. This is a product specification and not a recommended human dose.
Why doesn’t 17.5mg divided by 100 equal 170.50mcg?
The listed 17.5mg would mathematically average 175mcg across exactly 100 equal sprays. However, the supplied spray count is approximate and the stated product output is 170.50mcg per spray. Without additional dispensing information, the supplied 170.50mcg specification is preserved rather than altered.
Does the spray require refrigeration?
Yes. According to the supplied product information, it should be refrigerated after opening.
What is the shelf life?
The supplied shelf life is 6 months.
Research Use Disclaimer
This EROS peptides PT-141 / Oxytocin formulation is presented exclusively for controlled research, analytical evaluation, and applicable laboratory investigation. The listed spray output describes the supplied product specification and is not human dosing or administration guidance. This information does not provide therapeutic, diagnostic, sexual-health, medical, self-administration, or veterinary instructions. Experimental work should use appropriately designed controls and validated laboratory methodology.
| Net Content |
17.5mg |
|---|---|
| Brand |
OROS Research |
| Format |
Spray |

Reviews
There are no reviews yet.